869 results on '"de Ferranti, Sarah"'
Search Results
102. Ideal Cardiovascular Health, Cardiovascular Remodeling, and Heart Failure in Blacks: The Jackson Heart Study
103. Clinical response to lifestyle counseling for dyslipidemia and elevated blood pressure in childhood cancer survivors.
104. Childhood Cholesterol Disorders: The Iceberg Base or Nondisease?
105. Abstract P094: Awareness Of Cardiovascular Disease Is Low Among Young Women And Varies By Region
106. Variation in Pharmacologic Management of Patients with Kawasaki Disease with Coronary Artery Aneurysms
107. Comparative Effectiveness of Adolescent Lipid Screening and Treatment Strategies
108. Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
109. Pediatric aspects of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
110. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial
111. Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events
112. Activity During the COVID-19 Pandemic in Children with Cardiac Rhythm Management Devices
113. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children
114. Abstract 11584: Prevalence of Isolated Nocturnal Hypertension in Adolescents with Use of Adult Hypertension Criteria
115. Abstract 10889: Impact of the COVID-19 Pandemic on Ambulatory Pediatric Cardiology Care by Race/Ethnicity
116. Low-Density Lipoprotein Cholesterol Trajectories and Prevalence of High Low-Density Lipoprotein Cholesterol Consistent With Heterozygous Familial Hypercholesterolemia in US Children
117. The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia
118. Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype
119. Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic Patients
120. Coronary Artery Aneurysm Measurement and Z Score Variability in Kawasaki Disease
121. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of postacute sequelae of SARS-CoV-2 infection (PASC) in children and adolescents.
122. B-PO02-041 ACTIVITY DURING THE COVID-19 PANDEMIC IN CHILDREN WITH CARDIAC RHYTHM MANAGEMENT DEVICES
123. Detailed Assessment of Left Ventricular Function in Multisystem Inflammatory Syndrome in Children, Using Strain Analysis
124. Antibiotics for Acute Sinusitis in General Practice
125. Pediatric Lipid Screening and Treatment for Cardiovascular Disease Prevention: An Ounce or a Pound?
126. Rates of Cholesterol Screening of Youth—Reply
127. Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association
128. Abstract P032: Specialized Care Is Associated With Higher Cardiovascular Disease Awareness In Young Women
129. Improving Cardiovascular Health in a Pediatric Preventive Cardiology Practice
130. CARDIOVASCULAR HEALTH CHARACTERISTICS IN CHILDREN AND ADOLESCENTS WITH CONGENITAL HEART DISEASE
131. Socioeconomic and Racial and/or Ethnic Disparities in Multisystem Inflammatory Syndrome
132. Are Amoxycillin and Folate Inhibitors as Effective as Other Antibiotics for Acute Sinusitis? A Meta-Analysis
133. Pediatric Lipid Screening and Treatment in Canada: Practices, Attitudes, and Barriers
134. Cholesterol Testing Among Children and Adolescents During Health Visits
135. Using High-Dose Omega-3 Fatty Acid Supplements to Lower Triglyceride Levels in 10- to 19-Year-Olds
136. SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association.
137. Conducting Web-Based Focus Groups With Adolescents and Young Adults
138. Storm over statins - the controversy surrounding pharmacologic treatment of children
139. C-reactive protein: a nontraditional serum marker of cardiovascular risk
140. Atrioventricular Block in Children With Multisystem Inflammatory Syndrome
141. Evolocumab in Children with Heterozygous Familial Hypercholesterolemia
142. Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial
143. Update on Preventive Cardiology
144. The Changing Demographics of Congenital Heart Disease Hospitalizations in the United States, 1998 Through 2010
145. Hypertension in Children and Adolescents—More Questions Than Answers
146. Declining Cholesterol Levels in US Youths: A Reason for Optimism
147. Hypertriglyceridemia in a Pediatric Referral Practice: Experience With 300 Patients
148. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis
149. Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic
150. Anti-thrombosis management of patients with Kawasaki disease: Results from an international survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.